Month: May 2020

Image Sensing Systems, Inc. Announces 2020 First Quarter Results

Written by Customer Service on May 14, 2020. Posted in Public Companies.

SAINT PAUL, Minn., May 14, 2020 (GLOBE NEWSWIRE) — Image Sensing Systems, Inc. (Nasdaq: ISNS) today announced results for its quarter ended March 31, 2020.First Quarter 2020 Financial SummaryFirst quarter royalties were $2.1 million, an increase of 20 percent from the same period in the prior year.First quarter product sales were $1.1 million, a decrease of 35 percent from the same period in the prior year.Operating expenses totaled $2.8 million in the first quarter of 2020, an increase of 23 percent from the prior year period.Capitalized software costs in the first quarter were $22,000 compared to $419,000 in the prior year period.Net loss for the first quarter of 2020 totaled $111,000 compared to net income of $308,000 for the same period in the prior year.Cash balance increased to $5.4 million, up from $5.1 million at the end...

K92 Mining Inc. Releases Strong 2020 Q1 Financial Results

Written by Customer Service on May 14, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSXV: KNT; OTCQB: KNTNF) is pleased to announce results from its financial statements for the three months ended March 31, 2020.

ECN Capital Reports US$0.06 in Adjusted Earnings per Common Share in Q1-2020

Written by Customer Service on May 14, 2020. Posted in Public Companies.

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or the “Company”) today reported financial results for the three-month period ended March 31, 2020.For the three-month period ended March 31, 2020, ECN Capital reported Adjusted net income applicable to common shareholders from continuing operations of $14.5 million or $0.06 per share (basic) versus $18.5 million or $0.08 per share (basic) for the previous three-month period ended December 31, 2019 and $12.6 million or $0.05 per share (basic) for the same period last year.“ECN had strong Q1 earnings of $0.06, in line with our guidance of $0.06 – $0.07,” said Steven Hudson, CEO of ECN Capital Corp. “We never expected to have the sort of stress test we are all getting from Covid-19, but we are very pleased with the resiliency of each of our...

IntelGenx Reports First Quarter 2020 Financial Results

Written by Customer Service on May 14, 2020. Posted in Earnings Releases And Operating Results.

SAINT LAURENT, Quebec, May 14, 2020 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the first quarter ended March 31, 2020. All dollar amounts are expressed in U.S. currency, unless otherwise indicated, and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise.2020 First Quarter Financial Summary:Revenue was $202,000, compared to $416,000 in the 2019 first quarterAdjusted EBITDA was ($1.9 million), compared to ($2.1 million) in Q1-2019Cash and short-term investments totaled $4.4 million as at March 31, 2020Recent Developments:Announced a performance improvement program focused on generating near-term revenue, preserving the Company’s resources, extending...

CohBar Reports First Quarter 2020 Financial Results and Provides Business Update

Written by Customer Service on May 14, 2020. Posted in Earnings Releases And Operating Results.

MENLO PARK, Calif., May 14, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today reported its financial results for the first quarter ended March 31, 2020.“I am pleased to share with you that since my arrival at CohBar last May, we have expanded the number of programs from two to five with the newest targeting COVID-19 associated acute respiratory distress syndrome (ARDS),” said Steven Engle, CohBar’s Chief Executive Officer. “Recently, we announced that we have a new target for our CB5064 apelin agonist program, which is COVID-19 associated ARDS, an underlying disease that lacks adequate therapies. We are excited because published preclinical studies have shown that apelin can reduce the...

Eton Pharmaceuticals Announces First Quarter 2020 Financial Results

Written by Customer Service on May 14, 2020. Posted in Earnings Releases And Operating Results.

DEER PARK, Ill., May 14, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today reported financial results for the first quarter ended March 31, 2020 and provided an update on business progress.“The first quarter was an exciting period for Eton. We acquired marketing rights to orphan drug Alkindi Sprinkle and strengthened our balance sheet with an additional $9.8 million of liquidity,” said Sean Brynjelsen, CEO of Eton Pharmaceuticals. “While COVID-19 has impacted our Biorphen commercial launch, we remain in a strong financial position and we look forward to the potential for multiple additional product launches later this year.”First Quarter MilestonesAcquired U.S. marketing rights to Alkindi® Sprinkle. Eton acquired...

PeerStream Name Change to Paltalk, Inc. and New Ticker Symbol, “PALT” Effective Friday, May 15, 2020

Written by Customer Service on May 14, 2020. Posted in Public Companies.

NEW YORK, NY, May 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — PeerStream, Inc. (“PeerStream,” the “Company,” “we,” “our” or “us”) (OTCQB: PEER), a leading communications software innovator that powers multimedia social applications and developer of secure communications software, today announced that the Company’s corporate name has been changed from “PeerStream, Inc.” to “Paltalk, Inc.,” effective Friday, May 15, 2020, and that the change of its ticker symbol from “PEER” to “PALT” has been approved by the Financial Industry Regulatory Authority (FINRA). The Company’s common stock will continue to trade on the OTC Markets and begin trading under the new ticker symbol (OTCQB: PALT) (CUSIP 69764K106), effective at the opening of trading hours on Friday, May 15, 2020.As previously announced, the corporate name change reflects...

TG Therapeutics Announces Proposed Public Offering of Common Stock

Written by Customer Service on May 14, 2020. Posted in Public Companies.

NEW YORK, May 14, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases (“TG Therapeutics”), today announced that it intends to offer and sell 6,000,000 shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. TG Therapeutics intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering.TG Therapeutics intends to use the net proceeds of the public offering to fund the continued development of ublituximab and umbralisib, the potential in-license,...

OSS Reports Q1 2020 Revenue Up 33% to $13.4 Million

Written by Customer Service on May 14, 2020. Posted in Public Companies.

ESCONDIDO, Calif., May 14, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a global leader in specialized high-performance edge computing and AI on the Fly®, reported record results for its first quarter ended March 31, 2020.First Quarter 2020 Financial and Operational HighlightsRevenue increased 33% to a record first quarter of $13.4 million.Gross profit improved to $3.4 million or 25.4% of revenue.Secured design win for new mil-spec flash storage array for airborne sensor data collection, reflecting the unique capabilities of the company’s award-winning flash array technology.Introduced new OSS PCIe Gen 4 expansion system incorporating the latest NVIDIA V100S Tensor Core GPU. This system delivers data center capabilities to HPC and AI deployments at the edge. So far in 2020, the company has received more than $3.5...

Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Written by Customer Service on May 14, 2020. Posted in Public Companies.

NEWTON, Mass., May 14, 2020 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the first quarter ended March 31, 2020 and provided an update on the Company’s recent corporate developments.“Over the last several months, we made significant progress in the expansion and further diversification of our product pipeline with the recent addition of emetine, a broad-acting and potent antiviral for the treatment of COVID-19 patients,” said Chris Schelling, CEO and Founder of Acer. “We are very pleased to be collaborating with NCATS on the development of emetine and look forward to advancing this important program....

Month: May 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals